SIRT1 and cardiac hypertrophy: This domain isconsidered of clinical interest for the treatment of cardiovascular diseases [5,46], and themIGF-1/SirT1 pathway presented in this study may represent a promisingtherapeutic target to fight cardiac hypertrophy and oxidative stress.